SEC Form 4 · accession 0001209191-15-086311
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Benjamin Wu
Director
Period of report
Oct 8, 2015
Accepted (ET)
Dec 21, 2015 · 12:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 9, 2015 | S | 26,372 | $1.58 | D | 973,628 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (Right to Acquire)F2 | $0.00 | Oct 8, 2015 | A | 384,615 | A | — | — | Common Stock | 384,615 | 384,615 | D |
Explanation of responses
- F1These shares were sold by the Reporting Person in a private transaction.
- F2Issuable to the Reporting Person on the earlier of September 24, 2018 and the occurrence of certain events described in a letter agreement by and between the Issuer and the Reporting Person dated September 24, 2015 and attached as Exhibit 10.1 to Form 8-K filed with the Securities and Exchange Commission on October 8, 2015.